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The effects of Allium sativum on yogurt formation and subsequent storage 
(4°C, up to 28 days) on proteolysis, microbial activity, and inhibition of α-
amylase, α-glucosidase and angiotensin-I converting enzymes were 
investigated in vitro. Allium sativum yogurt showed higher rates of pH 
reduction and increment of titrable acid than control during the incubation at 
41°C. Highest proteolysis was observed on day 7 in Allium sativum yogurt 
(62.7±0.80 mgmL-1), which was 2-flod higher than the control (31.0±0.96 
mgmL-1). Bacterial counts in Allium sativum yogurt were higher for 
Lactobacillus spp. but lower for Streptoccus thermophilus (p<0.05) compared 
to those in the control throughout refrigerated storage. Highest inhibitory 
activities for α-amylase were recorded on day 14 of storage for Allium sativum 
and the control yogurt while highest inhibitory activities for α-glucosidase 
were recorded on day 7 of storage for Allium sativum and the control yogurt 
respectively. The highest angiotensin-I converting enzymes activity was 
observed on day 7 of the refrigerated storage in Allium sativum yogurt, and 
being more potent than the control. Allium sativum enhanced the fermentation 
of yogurt in favor of the population of Lactobacillus sp, stimulated proteolysis 
of milk proteins, and increased the in vitro inhibition of key enzymes 
associated with diabetes and hypertension. 
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Many fermented foods have anti-angiotensin-I 
converting enzyme (ACE-I) activities, majority of 
which are attributed to protein breakdown products 
Many fermented foods have ACE-I activities, 
majority of which are attributed to protein breakdown 
products [1]. As for fermented milks, the health 
benefits can be attributed to the products of microbial 
fermentation of milk carbohydrate, fat and protein 
[2]. Since the metabolic activities of these microbes 
are instrumental in producing characteristic meta-
bolites, the enhancement of microbial fermentation 
of milk can result in the production of more milk 
products with enhanced health benefits. Inclusion of 
plants or their extracts in the fermentation can thus 
increase functional properties of the fermented 
products as reported for tempeh [3], alcoholic 
beverages [4] and yogurt [5,6]. 
Garlic (Allium sativum L.) has special place in 
folk medication, and is used widely in preparing 
food. The medicinal benefits in frequent uses of 
garlic may be credited to the anti-microbial [7], anti-
thrambotic[8], anti-hypertensive [9], anti-hypergly-
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cemic [10], and anti-hyperlipemic [11] activities of 
this plant. In addition, commercially available garlic 
preparations in the form of garlic oil, garlic powder, 
and pills are widely used for certain therapeutic 
purposes such as for lowering blood pressure, and 
improving lipid profile [12]. Several of the beneficial 
effects of garlic on cardiovascular disorders can be 
attributed to garlic’s inhibitory effects on ACE-I [13] 
as demonstrated in vitro [14] and in vivo. The health 
beneficial effects of garlic may also be extended to 
diabetes and related disorders [15,16]. In fact, 
complications arising from diabetes mellitus are known 
to preclude the development of cardio-vascular 
disorders [8-10]. An increase in peptidyldipeptidase 
ACE activity has been reported in diabetic patients and 
diabetes-induced animals with cardiovascular 
disorders, nephropathy and retinopathy [8, 10, 11, 17], 
which lend support to the rational treatment with ACE 
inhibitors in the prevention of cardiovascular disorders 
and endothelial vascular dysfunction. 
Garlic may influence both the fermentation and the 
functional properties of fermented milk by virtue of the 
anti-bacterial effects on microbial growth and also 
presence of garlic bioactive phytochemicals. Therefore, 
the present study aimed to ascertain the effects of 
presence of A. sativum on: a) the fermentation of milk 
by yogurt bacteria, b) the viable microbes in the final 
product, c) the antioxidant activity, and d) the 
functional inhibition of key enzymes related to 
diabetes and hypertension.  
2. Materials and Methods 
2.1. Plant material 
 
Commercially available A. sativum powder 
(McCormick) was purchased in dried form from a 
local market in Malaysia. 
 
2.2. Aqueous extraction of A. sativum 
 
The powder was homogenized (polytron at 
maximum setting for 10 seconds) in distilled water in 
the ratio of 1:10 (wv-1). The mixture was incubated 
overnight (70°C), followed by centrifugation (2000 
rpm, 10 min, 4°C), and filtered by Whatman’s paper 
No. 5. The supernatant was harvested, stored at 4°C, 
and used within 3 days. 
 
2.3. Milk and yogurt bacteria 
 
Fresh, pasteurized and homogenized cow milk 
(4% full fat) was purchased from a local market. 
The dried yogurt bacteria mixture (Chris Hansen, 
Denmark) consisted of the following bacteria: 
Lactobacillus acidophilus LA-5, Bifidobacterium Bb-
12, Lactobacillus casei LC-01, and Streptococcus 
thermophilus at the ratio of 4:4:1:1. 
 
2.4. Preparation of starter culture 
 
Yogurt starter culture was prepared by 
inoculating 1 L of pasteurized full fat (4%) milk 
with dried yogurt bacteria (1% wv-1). The milk-
yogurt bacteria mixture was then incubated at 41°C 
for 12 h and the yogurt formed was stored at 4°C 
and used as starter culture within 1 week. We 
routinely found the pH of the starter culture at the 
range of 4.1-4.3 and viable bacteria to range 
between 2-5×106 cfug-1 and 6-10×108 cfug-1 for 
Lactobacillus spp. and S. thermophilus, respectively, 
on the 14th day of storage. 
 
2.5. Preparation of yogurt 
 
The control and herbal yogurt (A. sativum 
yogurt) were both prepared on the same day. Herbal 
water extract (100 ml) was added into pre-heated 
(41°C) pasteurized full fat (4%) milk (850 ml) 
followed by the addition of starter culture (50 ml) 
containing S. thermophilus, L. acidophilus, L. 
bulgaricus and B. bifida. Full fat milk powder (2 g; 
4% fat) was added to modify the milk’s solid 
content to 15% gml-1. The extract, starter culture and 
milk were mixed thoroughly, and aliquoted (100 ml) 
into disposable plastic containers. Control yogurt 
was prepared essentially in the same manner as 
herbal-yogurt with the exception that distilled water 
(100 ml) was used instead of herbal extract. The 
prepared yogurts were fermented in water bath 
(41°C) until pH was reduced to 4.5 followed by 
refrigeration (4˚C) (fresh yogurt or day 0 of storage) 
up to 28 days. 
 
2.6. Preparation of yogurt extract 
 
The control and herbal yogurts (10 g) were 
homogenized (polytron at maximum setting for 10 
seconds) with 2.5 ml of sterile distilled water. The 
pH of the yogurts was acidified to 4.0 (Mettler-
Toledo 320, Shanghai) with HCl (0.1 M). The 
yogurts were then heated in a water bath (45°C) for 
10 min prior to centrifugation (5000 g, 10 min, 4°C). 
The supernatants were harvested, and NaOH (0.1 
M) was added to adjust the pH to 7.0. The yogurt 
water extracts were re-centrifuged (5000 g, 10 min, 
4°C), and the supernatants were harvested and stored 
at -20°C for required analysis. 
 
2.7. pH and titrable acid (TA) determination  
 
 The yogurt samples were initially homogenized 
(polytron at maximum setting for 10 seconds) in 
distilled water 1:1 and 1:9 ratio prior to pH or TA 
determination, respectively [18]. The amount of acid 
produced was calculated as follows: 
Lactic acid (%) = VNaOH×0.1 N×10×0.009×100 
Where, V is the volume of NaOH required to 
neutralize the acid. 
 
2.8. Quantification of total phenolic content  
 
Total phenolic content (TPC) in the yogurts 
samples was quantified as described by Shetty, 
Vattem, & Clydesdale [11]. The reaction mixture 
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was prepared by mixing 1 ml of the yogurt extract 
with 1 ml of 95% ethanol and 5 ml of distilled water 
(dH2O) in a test tube. Folin-Ciocalteu reagent (diluted 
1:1 with distilled water) was added to each sample 
followed by thorough mixing using a vortex. After 5 
minutes, 1 ml of 5% Na2CO3 was added to the reaction 
mixture; then these mixtures were left to stand for 60 
min at room temperature. The absorbance readings 
were done at 725 nm. Standard curves were prepared 
by various concentrations of gallic acid (5-60 μgml-1) 
in methanol. The results were reported as microgram 
equivalents of gallic acid (GAE) per millilitre of the 
sample.  
 
2.9. Antioxidant activity of yogurt extract by 1,1-
diphenyl-2-picrylhydrazyl radical inhibition 
(DRI) assay 
 
The antiradical activity of yogurt extracts was 
determined using 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) method [17]. The yogurt extracts (250 ml) 
were added into 3 ml of 60 mmol-1L DPPH in 
ethanol (Sigma Aldrich, Germany). The decrease in 
absorbance was monitored at 517 nm until a constant 
reading was obtained. The constant readings for the 
yogurt extracts and control (consisting of 250 ml of 
water instead of extract) were used in the calculation 
of the inhibition percentage of DPPH (%DPPH) 
oxidation or free radical scavenging capacity (RSC) 
using the following formula: 
RSC (%) = 100×(Ablank–Asample/Ablank) 
 
2.10. O-Phthalaldehyde (OPA) assay 
 
Proteolysis products present in the yogurt water 
extracts were measured using o-phthaldialdehyde 
(OPA), which reacts with primary amines (functional 
group of peptides) in the presence of β-
mercaptoethanol [18]. Sodium tetraborate (Borax; 25 
ml 100 mM), sodium dodecyl sulphate (2.5 ml 20% 
of ww-1), 1.1 ml OPA (40 mg OPA dissolved in 1 ml 
methanol) and 100 µl β-mercaptoethanol (Sigma-
Aldrich, Germany) were mixed in 21.4 ml dH2O [20]. 
This reagent, prepared fresh on the day of assay, was 
protected from direct light, and used within 2 h of 
preparation. Aliquots of the yogurt water extract (30 
ml containing 5-100 mg proteins) were added directly 
to OPA reagent (1.0 ml) in a 1.5 ml quartz cuvette, 
and the solutions were mixed briefly by inversion 
prior to 2 min incubation at room temperature 
followed by absorbance (340  nm) measurement. The 
peptide concentration was estimated against the 
tryptone (Difco Laboratories, Sparks, MD, USA) 
standards (0.125-1.50 mgml-1). 
 
2.11. Enzyme inhibition 
2.11.1. Determination of the angiotensin I-
converting enzyme’s (ACE-I) inhibition activity 
 
Rabbit lung was used as a source of ACE-I. 
Fresh rabbit lung, removed immediately from the 
rabbit post-mortem, was snap-frozen to -20˚C 
followed by grinding using pestle and mortar, and 
subsequently, homogenized (polytron at maximum 
setting for 10 seconds) with ice-cold 0.05 M 
potassium phosphate buffer, pH 8.3 [21]. The 
homogenized rabbit lung was then centrifuged for 
60 min at 20000 g. The clear red supernatant 
possessed high ACE activity, and was aliquoted into 
1ml ampoules prior to freezing (-20˚C) for further 
analysis. All enzyme assays were carried out using 
yogurt water extracts at three different dosages. The 
ability of the yogurt extract to inhibit the activity of 
ACE-I to hydrolyse the substrate furanocryloyl 
tripeptide Phe–Gly–Gly (FAPGG; Sigma-Aldrich, 
St Louis, MO, USA) in the absence (dH2O) or 
presence of yogurt water extract (300, 250 or 
125µL) was measured according to the 
spectrophotometric (Thermo-spectronic 10 UV, 
190-1100 nm, USA) method [22]. Appropriate 
buffer volumes (50 or 175 µl, respectively) were 
added to the last two dosages to make up the volume 
to 300 µl. Absorbance at 340nm was recorded every 
5 min, and the linear rate of absorbance change was 
used in the calculation of enzyme activity (unit 
absmin-1). ACE-I inhibition was calculated as 
follows: 
ACE-inhibitory activity (%)=1-[(C-D)/ (A-B)×100] 
Where, 
A = Abs340nm (ACE solution in the buffer), 
B = Abs340nm (buffer), 
C = Abs340nm (ACE solution with the ACE 
inhibitory component added in the buffer), and 
D = Abs340nm (ACE inhibitory component in the 
buffer) 
 
2.11.2. α-amylase and α-glucosidase inhibition 
assays 
 
The α-amylase and α-glucosidase inhibition 
assays were adapted from Apostolidis, Kwon & 
Shetty [17] with absorbance measured at 540 nm 
and 404 nm, respectively. Three different doses of 
yogurt water extract used were 500, 250 and 125µl. 
appropriate buffer volumes (250 or 375µL, 
respectively) were added to the last two dosages to 
make up the volume to 500µl. The inhibition (%) of 
enzymes was calculated as below: 
Inhibition (%) = 
(Absorbance control–Absorbance of extracts/ 
Absorbance of control)×100 
 
2.11.3. Determination of IC50 
 
Enzyme inhibition, expressed in terms of IC50, is 
defined as the protein concentration (µgml-1) in the 
sample required to inhibit 50% of the enzyme 
activity. The protein concentration in all yogurt 
extracts was determined according to Bradford [22]. 
In the present study, each sample was adjusted to at 
least three levels of concentrations by standard 
volume dilution. The protein content of each sample 
was determined (µgml-1), and the IC50 was then 
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subjected to the non-linear adjustment programme 
(PRISM, version 4.02) for Windows (GraphPad 
Software, Inc. San Diego, CA, USA)) to determine 
the protein concentration in the sample (µgml-1) 
required inhibiting 50% of the ACE activity. 
 
2.12. Microbial viable cell count in yogurts 
 
Bacterial enumeration was determined by the 
spread-plating diluted (101 to 108 in sterile peptone 
water (2% wv-1) as diluent) samples of yogurts on 
agar. M.R.S. agar (anaerobic, 72 h, 37˚C, Oxoid, 
CM0361, Basingstoke, England) was used to 
enumerate Lactobacillus spp. whereas M17 agar 
(aerobic, 24 h, 37˚C, Oxoid, CM0785, Basingstoke, 
England) was used to enumerate S. thermophilus. 
Twenty grams of buffered peptone water was mixed 
with 1 L of distilled water, and the mixture was 
distributed into the final tubes followed by 
autoclaving (121˚C for 20 min).  
 
2.13. Statistical analysis 
 
A total of three separate experiments were 
carried out and assays were performed in triplicate. 
Data were expressed as mean ± standard deviation 
and the data were analyzed using SPSS 14.0 
(Chicago, IL, USA) for Windows. General Linear 
Model procedures and Tukey test for means 
comparison were used for determining significant 
difference at p < 0.05.  
3. Results and Discussion  
3.1 Effect of A. sativum on change of acidification 
of yogurt during the refrigerated storage 
 
PH value and acidity of the yogurt containing A. 
sativum and the control were measured during 4 
weeks of storage, and the results are shown in Fig 1.  
Initial pH value for A. sativum yogurt and control 
was 4.53±0.01 and 4.53±0.02, respectively. Yogurts 
TA value was in the range of 0.88±0.03 and 
0.92±0.01 lactic acid equivalent on day 0 of storage 
(fresh yogurt; at the point of incubation termination) 
(Fig. 2). Refrigerated storage for 28 days resulted in 
continued decrease in pH, and increase in the lactic 
acid production of both yogurts. A. sativum yogurt 
had the faster rate of pH reduction followed by the 
control. This resulted in the pH of A. sativum yogurt 
being the lower (4.15±0.01) on day 28 of storage 
followed by the control (4.26±0.01). The rate of acid 
formation in the A. sativum yogurt was higher than 
in the control. 
The high rate of change in pH with storage days 
could be due to the decomposition of fermentable 
substrates and sugars by microorganisms, especially 
Lactobacillus species, which ferment carbohydrates 
to produce energy and principally lactic acid. 
Higher increase (p≥0.05) of TA formation was 
observed in the A. sativum yogurt than in the control 
(1.17±0.1% and 1.06±0.02 % for A. sativum yogurt 
and control, respectively) in day 28 of storage. 
Lactic acid bacteria were reported as the major 
microorganisms that lead to milk fermentation and 
play important role to determine the quality of 
yogurt. Garlic is used most frequently as an 
ingredient in yogurt. Since ground garlic is used in 
yogurt, alliin is changed to aliicin. Allicin takes part 
in desirable fermentation of yogurt as it inhibits the 
growth of aerobic microorganisms derived from the 
sub-ingredients, and thus helps to propagation of 
LAB in milk fermentation. LAB was reported to be 
least sensitive to the inhibitory activity of garlic than 
other microorganisms [23]. However, different 
LABs showed different sensitivities to garlic. A. 
Sativum can either delay or stimulate milk 
fermentation depending on the LAB that is 
accounted. LAB produces organic acid, CO2 and 
ethanol, in addition to lactic acid, from hexoses or 
other sugars [24].  
 
3.2. Effect of A. sativum on total phenolic content 
& antioxidant capacity of yogurt during storage 
 
The total phenolic content in the homogenized 
yogurt extracts was analyzed by Folin-Ciocalteu 
method. The results indicated that the A. sativum 
yogurt had higher, but not significant, phenolic 




Figure 1. Changes of pH in the plain yogurt (control) 
and A. sativum yogurts during 28 days of storage at 4°C. 
Each experiment was repeated three times and values are 




Figure 2. Changes of titrable acid (TA) in the plain 
yogurt (control) and A. sativum yogurts during 28 days of 
storage at 4°C. Each experiment was repeated three times 
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Previous studies had same reports [17]. Refrigerated 
storage increased TPC in both yogurts on day 14 of 
storage (15.01±1.20 and 12.43±0.84, respectively), 
followed by gradual decrease during the next 7 days 
and increase again in day 28 of storage. Since plain-
yogurt contains no plant extracts, the TPC values in 
plain-yogurt reflect the phenolic compounds related 
to milk protein breakdown. Tyrosine, for instance, 
has a phenolic side chain suggested to give rise to 
the reading in TPC [6].  
A. sativum yogurt showed higher inhibition 
(p<0.05) of DPPH oxidation in vitro (45-52%) than 
that shown by the control (31-35%) during the 
refrigerated storage. A. sativum is known to be rich 
in phenolic compounds [25]; however, in the present 
study, the amount added into the yogurt was not 
large enough to cause differences in TPC in the 
control and A. sativum yogurts, which was in the 
range of 8-18 μgml-1 during the refrigerated storage 
(Fig. 3). Since the organosulfur compounds 
(diallylsulfide and s-allylcysteine) of A. sativum  
were quantified by the Folin-method, most of the 
increase in the antioxidant activities of A. sativum 
yogurt can be attributed to these garlic compounds 
[26]. 
The presence of A. sativum during yogurt 
formation increased the antioxidant activities in A. 
sativum yogurt compared to the control (53.2±1.2 and 
31.1±1.5 %, respectively; Fig. 3). 
Refrigerated storage resulted in gradual 
decreased antioxidant capacity (p<0.05) with 
prolonged storage and maximum values capacity 
recorded by A. sativum yogurt in contrast to the 
control, which was relatively unchanged throughout 
the storage period. The ability of A. sativum extracts 
to scavenge different radicals [27,28] was 
previously attributed to sulfur, phenolics, flavonoids 
and terpenoid compounds present in the mature garlic 
bulbs [29-31]. On the other hand, the free radical 
scavenging activity in yogurt can be attributed to the 
fermentation products as demonstrated by the two-
fold increase in antioxidant activity in the plain 
yogurt (control) compared to the fresh raw milk 
(8.11±0.23 %, table not shown). 
 
 3.3. Effect of A. sativum on viable cell count in 
yogurt during the storage 
 
The changes in the viable cell counts (VCC) of 
Lactobacillus spp. and S. thermophilus are presented 
in Table 1. The numbers of Lactobacillus spp. and 
S. thermophilus in fresh A. sativum yogurt (8.2±0.4× 
108 and 8.9±0.5×106 cfu-1ml, respectively) were 
marginally higher (p≥0.05) than in the control 
(7.8±0.5×108 and 8.85±0.3×106 cfuml-1, respectively). 
The survival of Lactobacillus spp. decreased 
gradually to 6.9±0.2×108 and 4.9±0.3×108 cfuml-1 in 
A. sativum yogurt and control, respectively, by day 28 
of storage. 
 
Figure 3. Total phenolic content (TPC) and antioxidant capacity 
(% inhibition of DPPH oxidation) by the plain yogurt (control) 
and A. sativum yogurts during 28 days of refrigerated (4˚C) 
storage. Each experiment was repeated three times, and values 
are means ± SD.  
 
VCCs of S. thermophilus in fresh yogurts were 
marginally higher in the A. sativum yogurt than in the 
control (8.9±0.5×106 and 8.4±0.6×106 cfuml-1, 
respectively). Both yogurts had increased viable S. 
thermophilus count on day 7 of storage in comparison 
to those in the fresh yogurt. Extended storage resulted 
in gradual decrease in S. thermophilus count in both 
yogurts until day 28 of storage. 
Refrigerated storage resulted victims in the cell 
numbers for both Lactobacillus spp. and S. 
thermophilus, and thus made the yogurt to have 
limited shelf life. Plant ingredients such as guar gum 
and cocoa or compound from plant (dextrose) were 
found to enhance the viability of probiotic in dairy 
products. In the present study, the inclusion of A. 
sativum in the yogurt increased LAB counts 
compared to the control. However, the reduction of 
Lactobacillus spp. VCC during the storage for both 
types of yogurt could be associated with the post-
acidification, which causes further reduction in pH. 
The reduction in S. thermophilus by days 14, 21 and 
28 of storage for A. sativum yogurt, respectively, 
may be attributed to the accumulation of organic 
acids and waste products such as hydrogen peroxide 
produced by the bacterial activity. Anti-microbial 
activities by most herbs and spices are attributed to 
the phenolic compounds present in these plants. 
These phenolic compounds could either alter 
microbial cell permeability, thus compromising the 
integrity of cells or interfering with the membrane 
functions important in the cell functions such as 
electron transport, nutrient uptake, protein and 
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Table 1. Comparison of the effects of A. sativum on the viability of Lactobacillus spp. (108cfu ml-1) and Streptococcus 
thermophilus (106cfu ml-1) in A. sativum yogurt and control during the storage at 4ºC. 
 
 Lactobacillus sp. counts (log10 CFUml




0  7  14  21  28  0  7  14  21 28  
Control 7.8±0.5ac 7.7±0.4ac 6.3±0.4bc 5.03±0.4bc 4.9±0.3ac 8.4±0.6ac 8.9±0.3ac 7.4±0.2bc 6.9±0.1ac 6.2±0.3ac 
A.sativum 
yogurt 
8.2±0.4ac 9.11±0.2bd 7.7±0.8ad 7.2±0.2ad 6.9±0.2ad 8.9±0.5ac 9.7±0.4bd 8.6±0.4ad 7.9±0.4bd 7.2±0.3ad 
 
a b Means in the same row with different alphabets are significantly different (p < 0.05) for each type of yogurt. 
c d Means in the same column with different alphabets are significantly different (p < 0.05) for the same storage day. 
Each experiment was repeated three times and values are means ± SD 
 
 A. sativum is rich in phenolic compounds, and is 
known to have anti-microbial actions against several 
pathogenic bacteria [33] but apparently not on the 
yogurt bacteria and probiotic as shown in the 
present study. 
 
3.4. Proteolysis of milk protein in yogurt 
 
The OPA-based spectrophotometric assay, which 
quantitates α-amino groups, reflects the extent of 
proteolytic activity [20]. OPA values were higher in 
fresh yogurts in the presence of A. sativum 
(54.8±2.48mgml-1) compared to the control (27.0±1.55 
mgmL-1, p<0.05). OPA values were highest on day 7 
of storage, followed by a consistent reduction until 
day 28 of storage for both yogurts (Table 2). This 
suggests that A. sativum enhanced microbial 
metabolic activity not only during the fermentation 
but also during the refrigerated storage. Since, 
Lactobacillus spp. and S. thermophilus counts were 
not significantly different between the two yogurt 
treatments, higher OPA value in A. sativum yogurt 
may implicate an increase in the metabolic activities 
of these bacteria in the presence of A. sativum. The 
high OPA values coincide with the lowest pH and 
highest percentage of TA on day 7 (Figs.1 and 2). 
Reduced OPA values in both treatments from day 7 
to day 14 may be a combination of reduced release of 
exogenous proteases as a consequence of increased 
acidity that restricts further growth of the microbes 
and continued uptake of peptides by microbes for 
nitrogenous sources [34]. In addition, accumulation  
 
 
of waste products such as hydrogen peroxide [35] 
may also restrict the growth and survival of yogurt 
bacteria; this was also evident in the present study. 
 
3.5.Angiotensin-Converting Enzyme Inhibition 
(ACE-I) 
 
ACE-I activity was inhibited by yogurts in a dose-
dependent manner (data not shown).  
A. sativum extracts (at the same concentration used in 
A. sativum-yogurt) exert small inhibition on ACE 
activity (13%), and this could be attributed to 
phytochemicals such as mycerene and allicin in A. 
sativum [36]. A. sativum yogurt showed much higher 
ACE-I inhibition (62%) compared to the control 
(46%). 
Refrigerated storage increased the inhibitory effects 
of both yogurts on in vitro enzyme activity (Table 2). 
The IC50 in fresh control (day 0; 15.4± 0.7 mgg
-1) was 
reduced (p<0.05) to 9.7±0.1 mgg-1 on day 7 of storage 
but increased to 12.7±0.6 mgg-1, 14.7±0.7 mgg-1 and 
27.7±1.3 mgg-1 on days 14, 21 and 28, respectively. 
Lowest IC50 value coincides with highest OPA values 
observed on day 7. 
A. sativum yogurt showed similar changes in the 
potency of ACE inhibition as a result of refrigerated 
storage. Lowest IC50 value (6.9±0.23 mgg
-1) was 
observed on day 7 of storage, which was lower 
(p<0.05) than that of the control. Fresh yogurt is 
known to contain biologically active proteins, which 
increase during the storage as a result of microbial 
proteolysis of the milk proteins [37]. 
 
Table 2. Comparison of the effects of A. sativum on OPA peptides and angiotensin-1 converting enzyme (ACE) in A. 
sativum yogurt and control during storage at 4°C 
 
 OPA peptides (mgml-1) IC50 (mgg
-1) for ACE2 
Storage 
(day) 














































a bMeans in the same row with different alphabets are significantly different (p < 0.05) for each type of yogurt. 
c dMeans in the same column with different alphabets are significantly different (p < 0.05) for the same storage day. 
1O-phthalaldehyde assay for peptides using calibrated curve of tryptone standards 
2 IC50 values were calculated by subjecting ACE-inhibition by 125, 250 and 500ul yogurt water extracts to a non-linear adjustment 
programme (PRISM  version 4.02 for Windows (GraphPad Software, Inc. San Diego, CA, USA). 
Each experiment was repeated three times and values are means ± SD. 
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The greater inhibitory effects of A. sativum yogurt on 
ACE-I activity suggest positive effects of A. sativum 
on yogurt bacteria during the fermentation and refri-
gerated storage, as evident from enhanced acidify-
cation of yogurt and proteolysis of milk protein. 
The difference in IC50 values for ACE-I in fresh 
yogurts (15.4±0.66 and 12.9±0.37 mgg-1 for the control 
and A. sativum yogurts, respectively) indicates that 
peptides in A. sativum yogurt were more active than 
those in the control yogurt.  
Furthermore, the higher proteolytic activity in the 
A. sativum-yogurt compared to the control during the 
first 7 days of refrigerated storage could have resulted 
in the formation of more bioactive peptides in the 
treatment sample (A. sativum yogurt) (IC50 values of 
9.7±0.12 mgg-1 and 6.9±0.23 mgg-1 for the control 
and A. sativum yogurts, respectively).Fermented milk 
products, containing biologically active peptides 
valyl-prolyl-proline (Val-Pro-Pro) and isoleucyl-
prolyl-proline (Ile-Pro-Pro), were shown to lower 
blood pressure in spontaneously hypertensive human 
model. These peptides act as ACE inhibitors, which 
will bind to the enzyme competitively, and in the case 
of ACE-I assay, prevent the breakdown of substrate, 
furanacryloyl-Phe-Gly-Gly (FAPGG) to furanacryloyl-
Phe (FAP) and Gly-Gly. Hence, variations in the 
proteolytic capabilities of different yogurts, such as 
those demonstrated in the present study, may be 
related to the corresponding variations in the ACE-I 
inhibitory potential of yogurt extracts reported earlier 
[38]. The length of storage time and conditions of the 
storage were found to have crucial effect on the 
formation and further breakdown of protein into 
inactive peptides and amino acids [39]. Both the A. 
sativum and control yogurts showed inhibitory 
activities, which may be related to the formation of 
new small protein fragments from the proteolysis of 
milk proteins during the storage at 4°C. In fact, there 
was correlation between the ACE inhibition of 
yogurts (IC50) and the OPA values that were found 
to be present for both of the A. sativum and control 
yogurts (R2=0.48 and 0.57, respectively). In the case 
of A. sativum yogurt, faster rate of pH reduction and 
higher TA contents (Figs. 1 and 2) suggested faster 
microbial growth and possibly higher microbial 
population at the end of the fermentation. Detailed 
studies are required to establish the changes in 
yogurt microbial population during the fermentation 
and refrigerated storage to substantiate the 
relationship between the formation of bioactive 
peptides and ACE-1 activity. Nevertheless, the 
present study showed that the proteolysis of milk 
proteins has occurred in the presence of A. sativum 
may in a manner such that the quantity (Table 2; OPA 
peptides) and quality (Table 2; IC50) of peptides 
formed were advantageous with respect to the 
inhibition of ACE-I activity. 
 
3.6. α-Amylase and α-glucosidase inhibition 
 
The IC50 values were reduced during the 
refrigerated storage of yogurts for α-amylase (the first 
14 days) and α-glucosidase (the first 7 days) followed 
by an increase in the fresh yogurts thereafter (Table 
3). The IC50 value of A. sativum yogurt and control 
for α-amylase on the day 14 of storage was 13.7±1.99 
and 26.3±2.15 mgg-1, respectively, whereas this value 
for α-glucosidase on day 7 was 120.7±22.71 mgg-1 
and 192.3±33.24 mgg-1, for A. sativum yogurt and 
control respectively. The inhibition of both α-amylase 
and α-glucosidase activities by A. sativum yogurt was 
higher (p<0.05) than that of the control yogurt 
throughout the 28 days of storage. A. sativum by itself 
showed little inhibitory effects (p≥0.05) on the 
inhibition of α-amylase and α-glucosidase (data not 
shown). 
This suggests that the phytochemical compounds 
in A. sativum alone had little effect on the inhibition 
of the digestive enzymes, and that the observed 
enzyme inhibiting activity by A. sativum yogurt may 
be attributed to fermentation products. The inhibition 
of -glucosidase, but not -amylase, by A. sativum 
yogurt can be attributed to the peptide contents in this 
yogurt since both enzymes were found to be 
correlated (r2 =0.45). 
 
Table 3. Comparison of the effects of A. sativum on IC50 1 of α-amylase and α-glucosidase in A. sativum yogurt and 
control during storage at 4ºC 
 IC50 (mgg
-1) for α-amylase2 IC50 (mgg
-1) for α-glucosidase3 
Storage 
(day) 




















































































 Means in the same row with different alphabets are significantly different (p < 0.05) for each type of yogurt. 
c d
 Means in the same column with different alphabets are significantly different (p < 0.05) for the same storage day. 
1 
IC50 values were calculated by subjecting ACE-inhibitions caused by 125, 250 and 500μl yogurt water extracts to a non-linear 
adjustment programme (PRISM version 4.02 for Windows (GraphPad Software, Inc. San Diego, CA, USA)). 
2
 Porcine pancreatic α-amylase (Sigma-Aldrich, USA) 
3 
Baker yeast α-glucosidase (Sigma-Aldrich, USA) 
Each experiment was repeated three times and values are means ± SD
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Furthermore, the correlation of these two 
enzymes’ inhibition with the antioxidant activities of 
yogurts is almost nonexistence (r2<0.10), although 
there are reports showing that antioxidants in dietary 
products may contribute to certain level of diabetic 




The presence of A. sativum enhanced 
fermentation and post-acidification of yogurt during 
the refrigerated storage via the retention of the 
viability of yogurt bacteria. A. sativum increased the 
capacity of yogurts to inhibit ACE-I, amylase and 
glucosidase in vitro; and these are correlated with the 
extent of milk protein proteolysis during fermentation 
and refrigerated storage. Inhibition of ACE-I is 
considered a useful therapeutic approach in the 
treatment of high blood pressure in both diabetic and 
non-diabetic patients. In addition, production of foods 
with ACE-inhibitory peptides such as yogurt may 
also be beneficial for individuals with increased blood 
pressure. ACE-inhibitory peptides are encrypted 
within the intact milk proteins; these peptides must be 
liberated from the proteins by specific enzymatic 
hydrolysis to exert their health effects. In this regard, 
it would be interesting to establish the sustained 
survival of yogurt bacteria in the presence of A. 
sativum that causes enhancement of milk protein 
proteolysis favouring the liberation of ACE inhibitory 
peptides at higher rate than that in control yogurt 
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